Procter & Gamble (PG) Financials

Procter & Gamble’s fiscal Q1 2027 results show solid top-line growth and strong cash generation, but also some pressure on margins and a more leveraged balance sheet. Revenue increased to $23.3 billion from $22.4 billion in the restated year-ago quarter, a gain of approximately 4%. Operating income rose to $5.9 billion from $5.856 billion, while net income was essentially flat at $4.757 billion compared with $4.781 billion. Diluted earnings per share improved to $1.97 from $1.95, helped by a lower share count.

Profitability was mixed. Gross profit increased to $12.0 billion, but the gross margin declined to approximately 49.8% from 51.4% a year earlier. Operating margin also narrowed to about 25.5% from 26.2%. This suggests that higher sales were partly offset by increased product costs and other operating pressures, even though selling, general and administrative expense declined to $5.7 billion from $6.0 billion.

Cash generation remains a major strength. Operating cash flow rose to $5.8 billion from $5.4 billion, and capital expenditures increased to $1.4 billion. That produced estimated free cash flow of approximately $4.4 billion, up modestly from roughly $4.2 billion in the prior-year quarter. P&G returned $3.9 billion to shareholders through dividends and share repurchases during the quarter.

The balance sheet held more cash, with cash and equivalents rising to $15.4 billion from $11.2 billion at the end of fiscal Q1 2026. However, total debt of approximately $38.9 billion exceeded cash, and current liabilities remained above current assets. The company also carried approximately $62.6 billion of goodwill and intangible assets, representing a significant portion of total assets.

• Revenue growth improved: Fiscal Q1 2027 revenue rose approximately 4% year over year to $23.3 billion, continuing the longer-term trend from roughly $19.5 billion in Q4 2022 to current quarterly sales.
• Cash generation remained strong: Operating cash flow increased approximately 7% year over year to $5.8 billion, while estimated free cash flow rose to about $4.4 billion.
• Shareholder returns remain substantial: P&G paid $2.6 billion in dividends and repurchased $1.25 billion of stock in Q1 2027, supporting per-share earnings and the company’s income-oriented investment appeal.
• Per-share earnings improved: Diluted EPS increased to $1.97 from $1.95, despite nearly flat net income, as the weighted-average diluted share count declined from approximately 2.337 billion to 2.318 billion.
• Liquidity strengthened: Cash and equivalents increased to $15.4 billion, up from $9.1 billion in Q3 2025 and $8.2 billion in Q4 2023, providing a larger cushion for dividends, debt maturities and capital investment.
• Capital investment is rising: Capital expenditures increased to $1.4 billion from $1.2 billion in the year-ago quarter. This reduces near-term free cash flow but may support future production capacity and brand growth.
• Operating performance remains resilient but uneven: Operating income has generally remained between roughly $4 billion and $6 billion per quarter over the supplied period, while quarterly revenue has trended higher, indicating stability with limited margin expansion.
• Gross margins contracted: The gross margin fell to approximately 49.8% from 51.4% a year earlier, indicating that cost inflation, product mix or pricing pressure is absorbing part of the revenue growth.
• Operating margins also narrowed: Operating margin declined to approximately 25.5% from 26.2%, showing that higher sales have not yet translated into proportional operating-profit growth.
• Current liquidity remains tight and debt is elevated: Current liabilities of $45.0 billion exceeded current assets of $32.5 billion, while total debt was approximately $38.9 billion. The company’s ability to sustain dividends and buybacks will continue to depend on its strong operating cash flow.